All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 28, 2023
Home » Topics » Science, BioWorld MedTech

Science, BioWorld MedTech
Science, BioWorld MedTech RSS Feed RSS

BioWorld MedTech’s Diagnostics Extra for Jan. 16, 2020

Jan. 16, 2020
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 15, 2020

Jan. 15, 2020
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More

BioWorld MedTech’s Oncology Extra for Jan. 14, 2020

Jan. 14, 2020
By Mark McCarty and Anette Breindl
No Comments
Keeping you up to date on recent developments in oncology.
Read More

BioWorld MedTech’s Cardiology Extra for Jan. 13, 2020

Jan. 13, 2020
By Liz Hollis
No Comments
Keeping you up to date on recent developments in cardiology.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 10, 2020

Jan. 10, 2020
By Andrea Applegate
No Comments
Keeping you up to date on recent developments in neurology.
Read More

BioWorld MedTech’s Diagnostics Extra for Jan. 9, 2020

Jan. 9, 2020
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 8, 2020

Jan. 8, 2020
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More
Tau protein in Alzheimer's disease

Tau PET imaging offers the potential to predict the progress of Alzheimer’s disease

Jan. 7, 2020
By Stacy Lawrence
No Comments
Amyloid and tau proteins are both involved in the disease pathology of Alzheimer’s disease. The diagnostic and treatment research focus has long been on amyloid, which has proven almost entirely fruitless after decades of effort. But tau is becoming better understood, as investigational tau imaging agents offer the ability to visualize its presence in the brain.
Read More

Glutamine transporter variant identified as new cancer target

Jan. 7, 2020
By John Fox
No Comments
A mitochondrial glutamine transporter variant of the SLC1A5 gene is a key regulator of glutamine metabolism and metabolic reprogramming in cancer cells, and targeting such transporters could be a new strategy for controlling tumor growth, Korean researchers reported online in the Dec. 19, 2019, edition of Cell Metabolism.
Read More

BioWorld MedTech’s Oncology Extra for Jan. 7, 2020

Jan. 7, 2020
By Mark McCarty and Anette Breindl
No Comments
Keeping you up to date on recent developments in oncology.
Read More
Previous 1 2 … 47 48 49 50 51 52 53 54 55 … 59 60 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 27, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 27, 2022.
  • Biogen, Eisai win FDA clearance for AD therapy Leqembi

    BioWorld
    As expected, the U.S. FDA gave its go-ahead to lecanemab, an amyloid-beta binder for mild cognitive impairment caused by Alzheimer’s disease (AD) and mild AD –...
  • Stem-cells2.png

    J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM

    BioWorld
    After long years of painstaking work, the commercialization of cell and gene therapies picked up pace in 2022, with multiple approvals. More progress is expected...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing